{
    "medicine_id": "7ff84fe5ce7f5134281dc5894940a5dc6949e8fb",
    "platform_id": "3834",
    "metadata": {
        "name": "Zeffix 100 mg film coated tablets",
        "composition": "Each film coated tablet contains 100 mg lamivudine For the full list of",
        "clinical_particulars": {
            "therapeutic_indications": "Zeffix is indicated for the treatment of chronic hepatitis B in adults with compensated liver disease with evidence of active viral replication persistently elevated serum alanine aminotransferase ALT levels and histological evidence of active liver inflammation and or fibrosis Initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier is not available or appropriate see section 5 1 decompensated liver disease in combination with a second agent without cross resistance to lamivudine see section 4 2",
            "contraindications": {
                "disease": "Hypersensitivity to the active substance or to any of the excipients listed in section 6 1",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Microcrystalline cellulose;Sodium starch glycolate;Magnesium stearate;Hypromellose;Titanium dioxide;Macrogol 400;Polysorbate 80;Synthetic yellow and red iron oxides",
                "incompatibilities": "Not applicable"
            }
        },
        "revision_date": "2022-02-28"
    }
}